Ivan Zeljkovic1, Sven Knecht2,3, Florian Spies2,3, Tobias Reichlin2,4, Stefan Osswald2,3, Michael Kühne2,3, Christian Sticherling2,3. 1. Cardiology, University Hospital Basel, Petersgraben 4, 4031, Basel, Switzerland. ivanzeljkov@gmail.com. 2. Cardiology, University Hospital Basel, Petersgraben 4, 4031, Basel, Switzerland. 3. Cardiovascular Research Institute Basel, Basel, Switzerland. 4. Department of Cardiology, Inselspital, Bern University Hospital, Bern, Switzerland.
Abstract
BACKGROUND: Atrial fibrillation recurrence (AFR) is common after pulmonary vein isolation (PVI), and the rate does not differ between radiofrequency (RF) and cryoballoon (CB) ablation. The aim of this study was to assess the impact of the ablation modality used at the index PVI on the outcome after redo PVI in patients with paroxysmal AF. METHODS: In this prospective, single-center, non-randomized study, consecutive patients with paroxysmal AF who have undergone the index PVI with either RF ablation (RF group) or 2nd-generation CB (CB group) were included. The primary endpoint was freedom from recurrence of atrial arrhythmia lasting > 30 s. RESULTS: A total of 105 patients undergoing redo PVI for paroxysmal AF were included (median age 61 years; 24% female; left ventricular ejection fraction (LVEF) 57 ± 8%; left atrial volume index (LAVI) 34 ± 11 mm). Index PVI was done either with focal RF (n = 81) or with CB (n = 24) and redo PVI only with focal RF. Total procedure time (139 vs. 113 min, p = 0.10) and RF delivery time (1017 vs. 870 s, p = 0.33) of the redo PVI were not significantly different. After a median follow-up of 371 (185-470) days, there were no differences between the RF and CB groups regarding the AFR rate after the second PVI (24 vs. 23%, p = 0.89). The Kaplan-Meier analysis showed no difference between the groups regarding AFR freedom time (p = 0.81). In multivariable logistic regression, only coronary artery disease was identified as an independent long-term predictor of AFR (OR 4.15, 95% CI 1.17-14.71, p = 0.027). CONCLUSIONS: The ablation modality used at the index PVI has no impact on long-term outcome after redo PVI in patients with paroxysmal AF.
BACKGROUND:Atrial fibrillation recurrence (AFR) is common after pulmonary vein isolation (PVI), and the rate does not differ between radiofrequency (RF) and cryoballoon (CB) ablation. The aim of this study was to assess the impact of the ablation modality used at the index PVI on the outcome after redo PVI in patients with paroxysmal AF. METHODS: In this prospective, single-center, non-randomized study, consecutive patients with paroxysmal AF who have undergone the index PVI with either RF ablation (RF group) or 2nd-generation CB (CB group) were included. The primary endpoint was freedom from recurrence of atrial arrhythmia lasting > 30 s. RESULTS: A total of 105 patients undergoing redo PVI for paroxysmal AF were included (median age 61 years; 24% female; left ventricular ejection fraction (LVEF) 57 ± 8%; left atrial volume index (LAVI) 34 ± 11 mm). Index PVI was done either with focal RF (n = 81) or with CB (n = 24) and redo PVI only with focal RF. Total procedure time (139 vs. 113 min, p = 0.10) and RF delivery time (1017 vs. 870 s, p = 0.33) of the redo PVI were not significantly different. After a median follow-up of 371 (185-470) days, there were no differences between the RF and CB groups regarding the AFR rate after the second PVI (24 vs. 23%, p = 0.89). The Kaplan-Meier analysis showed no difference between the groups regarding AFR freedom time (p = 0.81). In multivariable logistic regression, only coronary artery disease was identified as an independent long-term predictor of AFR (OR 4.15, 95% CI 1.17-14.71, p = 0.027). CONCLUSIONS: The ablation modality used at the index PVI has no impact on long-term outcome after redo PVI in patients with paroxysmal AF.
Authors: Andrzej Glowniak; Adam Tarkowski; Piotr Fic; Katarzyna Wojewoda; Jaroslaw Wojcik; Andrzej Wysokinski Journal: J Cardiovasc Electrophysiol Date: 2019-04-15
Authors: Sven Knecht; Christian Sticherling; Stefanie von Felten; David Conen; Beat Schaer; Peter Ammann; David Altmann; Stefan Osswald; Michael Kühne Journal: Int J Cardiol Date: 2014-07-02 Impact factor: 4.164
Authors: Arash Aryana; Sheldon M Singh; Giacomo Mugnai; Carlo de Asmundis; Marcin Kowalski; Deep K Pujara; Andrew I Cohen; Steve K Singh; Charles E Fuenzalida; Nelson Prager; Mark R Bowers; Padraig Gearoid O'Neill; Pedro Brugada; André d'Avila; Gian-Battista Chierchia Journal: J Interv Card Electrophysiol Date: 2016-07-30 Impact factor: 1.900
Authors: Paulus Kirchhof; Stefano Benussi; Dipak Kotecha; Anders Ahlsson; Dan Atar; Barbara Casadei; Manuel Castella; Hans-Christoph Diener; Hein Heidbuchel; Jeroen Hendriks; Gerhard Hindricks; Antonis S Manolis; Jonas Oldgren; Bogdan Alexandru Popescu; Ulrich Schotten; Bart Van Putte; Panagiotis Vardas; Stefan Agewall; John Camm; Gonzalo Baron Esquivias; Werner Budts; Scipione Carerj; Filip Casselman; Antonio Coca; Raffaele De Caterina; Spiridon Deftereos; Dobromir Dobrev; José M Ferro; Gerasimos Filippatos; Donna Fitzsimons; Bulent Gorenek; Maxine Guenoun; Stefan H Hohnloser; Philippe Kolh; Gregory Y H Lip; Athanasios Manolis; John McMurray; Piotr Ponikowski; Raphael Rosenhek; Frank Ruschitzka; Irina Savelieva; Sanjay Sharma; Piotr Suwalski; Juan Luis Tamargo; Clare J Taylor; Isabelle C Van Gelder; Adriaan A Voors; Stephan Windecker; Jose Luis Zamorano; Katja Zeppenfeld Journal: Europace Date: 2016-08-27 Impact factor: 5.214
Authors: Karl-Heinz Kuck; Alexander Fürnkranz; K R Julian Chun; Andreas Metzner; Feifan Ouyang; Michael Schlüter; Arif Elvan; Hae W Lim; Fred J Kueffer; Thomas Arentz; Jean-Paul Albenque; Claudio Tondo; Michael Kühne; Christian Sticherling; Josep Brugada Journal: Eur Heart J Date: 2016-07-05 Impact factor: 29.983
Authors: Sven Knecht; Ivan Zeljkovic; Michael Kühne; Christian Sticherling; Patrick Badertscher; Philipp Krisai; Florian Spies; Jan Vognstrup; Nikola Pavlovic; Sime Manola; Stefan Osswald Journal: J Interv Card Electrophysiol Date: 2022-08-18 Impact factor: 1.759